跳至主要内容
临床试验/JPRN-UMIN000012813
JPRN-UMIN000012813已完成未知

Phase II trial as new adjuvant chemotherapy regimen for capecitabine in stage II and III colorectal cancer. - Phase II trial as new adjuvant chemotherapy regimen for capecitabine

Tsukasa Hotta0 个研究点目标入组 25 人开始时间: 2014年1月20日最近更新:
适应症

试验速览

阶段
未知
状态
已完成
发起方
入组人数
25

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20years-old 至 ot applicable(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1.Pregnant female 2.It may be pregnant state female 3.Past history of malignant disease 4.There is uncontrolled cerebrovascular disease 5.There was serious allergy for fluorouracl related drug 6.There was allergy due to the lack of DPD 7.There is uncontrorable infection disease 8.It is difficult to intake oral food 9.Judgementof study controlled doctor

研究者

发起方
Tsukasa Hotta

相似试验

Phase II trial as new adjuvant chemotherapy regimen... | 临床试验